Brazil after the vote: new challenges in health and science for the next 4 years
The Lancet Regional Health – Americas
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(26)00343-1/fulltext?dgcid=raven_jbs_etoc_email
Brazil is home to nearly a third of the people of Latin America and the Caribbean, so its health policy carries weight across the region. On Oct 25, 2026, Luiz Inácio Lula da Silva was re-elected president and on Jan 5, 2027, the left-wing leader begins an unprecedented fourth term with a mandate from a divided country. His third term sought to expand public health policies and a health system weakened by the COVID-19 pandemic and the previous administration's response. The next term should be assessed on whether these efforts will translate into better prevention, preparedness, and timely access to care.
Health care in Brazil begins with the Unified Health System (Sistema Único de Saúde [SUS]). The SUS provides free universal care for approximately 214 million people. The principal health commitments in Lula's Government plan centre on expanding and strengthening the SUS through its main programmes: Mais Médicos (More Doctors), which places doctors in underserved areas; Agora Tem Especialistas (Now There Are Specialists), which expands specialist care, partly through private providers; and Farmácia Popular (People's Pharmacy), which supplies medicines for hypertension, diabetes, and other chronic conditions free of charge. By the Government's account, since 2023, Mais Médicos roughly doubled in size and coverage rose for 15 of the 16 main childhood vaccines. Moreover, the SUS performed a record number of elective surgeries in 2025. Sustaining this expansion will require stable financing and efficient spending.
https://www.thelancet.com/journals/lanam/issue/vol63nonull/PIIS2667-193X(26)X2008-7